12
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Impact of COMT Val158Met on executive functioning in the context of HIV and methamphetamine

, , , , , & show all
Pages 1-11 | Published online: 14 Jan 2010

References

  • Anderson SW, Tranel D. Neuropsychological consequences of dysfunction in human dorsolateral prefrontal cortex. In: Handbook of Neurophysiology. Grafman J, editor. Vol 7. 2nd ed. Amsterdam: Elsevier; 2002. pp. 145.
  • Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol  Soc. 2002;8(3):410–424.
  • Gonzalez R, Rippeth JD, Carey CL, et al. Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure. Drug Alcohol Depend. 2004;76(2):181–190.
  • Rippeth JD, Heaton RK, Carey CL, et al. Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons. J Int Neuropsychol Soc. 2004;10(1):1–14.
  • Scott JC, Woods SP, Matt GE, et al. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychol Rev. 2007;17(3):275–297.
  • Grant I, Heaton RK, Atkinson JH. Neurocognitive disorders in HIV-1 infection. HNRC group. HIV neurobehavioral research center. Curr  Top Microbiol Immunol. 1995;202:11–32.
  • Heaton RK, Grant I, Butters N, et al. The HNRC 500 – neuropsychology of HIV infection at different disease stages. HIV neurobehavioral research center. J Int Neuropsychol Soc. 1995;1(3):231–251.
  • White DA, Heaton RK, Monsch AU. Neuropsychological studies of asymptomatic human immunodeficiency virus-type-1 infected individuals. the HNRC group. HIV neurobehavioral research center. J Int  Neuropsychol Soc. 1995;1(3):304–315.
  • Starr JM, Fox H, Harris SE, Deary IJ, Whalley LJ.. COMT genotype and cognitive ability: A longitudinal aging study. Neurosci Lett. 2007;421(1):57–61.
  • Tunbridge EM, Harrison PJ, Weinberger DR. Catecholo-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol Psychiatry. 2006;60(2):141–151.
  • McCann UD, Wong DF, Yokoi F, Villemagne V, Dannals RF, Ricaurte GA. Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: Evidence from positron emission tomography studies with [11C]WIN-35,428. J Neurosci. 1998;18(20): 8417–8422.
  • Sekine Y, Iyo M, Ouchi Y, et al. Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET. Am J Psychiatry. 2001;158(8):1206–1214.
  • Berger JR, Kumar M, Kumar A, Fernandez JB, Levin B. Cerebrospinal fluid dopamine in HIV-1 infection. AIDS. 1994;8(1):67–71.
  • Larsson M, Hagberg L, Forsman A, Norkrans G. Cerebrospinal fluid catecholamine metabolites in HIV-infected patients. J Neurosci Res. 1991;28(3):406–409.
  • Ellis R, Childers ME, Kumar AM, Kumar M, Goetz T, Caligiuri M. Decreased cerebrospinal fluid dopamine correlates with impaired motor skills in HIV-1 infection and methamphetamine dependence. San Diego, CA: Society for Neuroscience, 34th Annual Meeting; 2004 Oct 23–27.
  • Kumar AM, Fernandez J, Singer EJ, et al. Human immunodeficiency virus type 1 in the central nervous system leads to decreased dopamine in different regions of postmortem human brains. J Neurovirol. 2009;15(3):257–274.
  • Carboni E, Silvagni A. Dopamine reuptake by norepinephrine neurons: Exception or rule? Crit Rev Neurobiol. 2004;16(1–2):121–128.
  • Westerink BH, Spaan SJ. Simultaneous determination of the formation rate of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) in various rat brain areas. Brain Res. 1982;252(2):239–245.
  • Li T, Chen CK, Hu X, et al. Association analysis of the DRD4 and COMT genes in methamphetamine abuse. Am J Med Genet B Neuropsychiatr  Genet. 2004;129(1):120–124.
  • Chen J, Lipska BK, Halim N, et al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): Effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum  Genet. 2004;75(5):807–821.
  • Papaleo F, Crawley JN, Song J, et al. Genetic dissection of the role of catechol-O-methyltransferase in cognition and stress reactivity in mice. J Neurosci. 2008;28(35):8709–8723.
  • Egan MF, Goldberg TE, Kolachana BS, et al. Effect of COMT Val108/158 met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A. 2001;98(12):6917–6922.
  • Joober R, Gauthier J, Lal S, et al. Catechol-O-methyltransferase val-108/158-met gene variants associated with performance on the wisconsin card sorting test. Arch Gen Psychiatry. 2002;59(7):662–663.
  • Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal cognition. Am J Psychiatry. 2002;159(4):652–654.
  • Rosa A, Peralta V, Cuesta MJ, et al. New evidence of association between COMT gene and prefrontal neurocognitive function in healthy individuals from sibling pairs discordant for psychosis. Am J Psychiatry. 2004;161(6): 1110–1112.
  • Bruder GE, Keilp JG, Xu H, et al. Catechol-O-methyltransferase (COMT) genotypes and working memory: Associations with differing cognitive operations. Biol Psychiatry. 2005;58(11):901–907.
  • Barnett JH, Jones PB, Robbins TW, Muller U. Effects of the catechol-O-methyltransferase Val158Met polymorphism on executive function: A meta-analysis of the wisconsin card sort test in schizophrenia and healthy controls. Mol Psychiatry. 2007;12(5):502–509.
  • Barnett JH, Scoriels L, Munafo MR. Meta-analysis of the cognitive effects of the catechol-O-methyltransferase gene Val158/108Met polymorphism. Biol Psychiatry. 2008;64(2):137–144.
  • Mattay VS, Goldberg TE, Fera F, et al. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci U S A. 2003;100(10):6186–6191.
  • Carey CL, Woods SP, Gonzalez R, et al. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004;26(3):307–319.
  • Glatt SJ, Faraone SV, Lasky-Su JA, Kanazawa T, Hwu HG, Tsuang MT. Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol Psychiatry. 2009;14(9):885–893.
  • Zhang H, Morrison MA, Dewan A, et al. The NEI/NCBI dbGAP database: Genotypes and haplotypes that may specifically predispose to risk of neovascular age-related macular degeneration. BMC Med  Genet. 2008;9:51.
  • Robbins TW, Roberts AC. Differential regulation of fronto-executive function by the monoamines and acetylcholine. Cereb Cortex. 2007;17(Suppl 1):i151–i160.
  • Sweatt JD. Hippocampal function in cognition. Psychopharmacology  (Berl). 2004;174(1):99–110.
  • Raz N, Dahle CL, Rodrigue KM, Kennedy KM, Land S. Effects of age, genes, and pulse pressure on executive functions in healthy adults. Neurobiol Aging. 2009 Jun 24 [Epub ahead of print].
  • Nackley AG, Shabalina SA, Tchivileva IE, et al. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science. 2006;314(5807):1930–1933.